PeptideDB

Adamax

Pesquisa emergente

Next-Generation Semax Derivative | Nootropic Neuropeptide

Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration, researched for cognitive enhancement,

Dados moleculares e de pesquisa

Sequência
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-AGly-NH2
Peso molecular
1,032.24 Da
Meia-vida
8-10 hours
Alvos primários
bdnf, dopamine-receptor, serotonin-receptor
Vias (pesquisa)
injectable, oral
Armazenamento
Lyophilized: room temp or freezer. Reconstituted: 2-8°C for 14-30 days

Overview

Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration, researched for cognitive enhancement, neuroprotection, and neuroplasticity.

Mechanism of action

Crosses BBB via enhanced lipophilicity from adamantane; upregulates BDNF and TrkB receptor sensitivity; modulates dopamine, norepinephrine, and serotonin; stabilizes microtubules via ADNP-derived mechanisms; provides antioxidant and anti-inflammatory neuroprotection.

Key research findings

  • Enhanced cognitive function and mental clarity
  • Improved focus and complex task handling
  • Neuroprotection against oxidative stress
  • Neuroplasticity support through BDNF upregulation
  • Potential mood enhancement
  • Stress resilience through HPA axis modulation

Research applications

Cognitive

  • Cognitive Enhancement — Preliminary research suggests improvements in focus, mental clarity, memory consolidation, and complex task handling.
  • Neuroplasticity Support — BDNF upregulation and TrkB enhancement promote new neural connections and synaptic plasticity for long-term improvements.
  • Learning and Memory — May enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.

Neuroprotective

  • Stroke Recovery — Preliminary observations indicate improved neurological outcomes through oxidative stress reduction and neuronal repair.
  • Oxidative Stress Protection — Demonstrates antioxidant properties protecting against oxidative damage and inflammation-induced neuronal injury.
  • Neuronal Maintenance — Supports neuronal survival and growth through BDNF enhancement and microtubule stabilization.

Mood

  • Mood Enhancement — Influences serotonin and dopamine to elevate mood and reduce depressive symptoms through neurotransmitter modulation.
  • Anxiety Reduction — Anecdotal reports indicate reduced overwhelm and anxiety through balanced neurotransmitter activity.
  • Stress Resilience — HPA axis modulation may improve stress response and emotional well-being.

FAQ de Adamax

How does Adamax improve cognition differently than Semax?+

Adamax is a next-generation Semax derivative with C-terminal adamantane modification for enhanced lipophilicity and blood-brain barrier penetration. While parent Semax shows cognitive benefits, Adamax's superior stability and BBB crossing potentially enable stronger cognitive effects at lower doses and with more sustained action.

Can Adamax cause overstimulation if combined with other nootropics?+

Yes. Adamax shares BDNF upregulation with compounds like Noopept, so combining them risks excessive neurotropic effects. Start with lower doses and monitor for overstimulation, anxiety, or sleep disruption. Safe stacking requires careful dose titration and might be better avoided for most users.

What causes the headaches some people report on Adamax?+

Headaches are most common at higher doses (particularly above 300mcg). This likely relates to the potent dopamine, norepinephrine, and serotonin modulation combined with BDNF upregulation creating temporary neurochemical shifts. Starting at 100-200mcg and titrating slowly minimizes this risk.

How long do Adamax's cognitive effects last after stopping?+

Due to BDNF-mediated neuroplasticity improvements, cognitive benefits persist weeks or months beyond discontinuation. Peak neuroprotective and structural brain benefits appear by week 4+ with continuous use, but the neuronal changes induced by BDNF upregulation have lasting effects independent of the compound remaining in circulation.

References

  1. [1]A Nootropic Adrenocorticotropin Analog 4-10 Semax: 15 Years Experience in Its Design and Study (Parent Compound)Zhurnal Vysshei Nervnoi Deiatelnosti imeni I.P. Pavlova
  2. [2]Semax, an Analog of ACTH(4-10), Regulates BDNF and trkB Expression in the Rat Hippocampus (Parent Compound)Brain Research
  3. [3]The Efficacy of Semax in the Treatment of Patients at Different Stages of Ischemic Stroke (Parent Compound)Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
  4. [4]The Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia (Parent Compound)BMC Genomics
  5. [5]The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's DiseaseInternational Journal of Molecular Sciences
  6. [6]Semax, a Copper Chelator Peptide, Decreases Cu(II)-Catalyzed ROS Production and Cytotoxicity of AbetaBioinorganic Chemistry and Applications
  7. [7]Semax Peptide Targets Mu Opioid Receptor Gene Oprm1 for Functional Recovery After Spinal Cord InjuryBritish Journal of Pharmacology

Peptídeos relacionados